Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 40% ± 22% | |
lung | 13 studies | 31% ± 10% | |
peripheral blood | 9 studies | 25% ± 12% | |
kidney | 7 studies | 28% ± 7% | |
heart | 6 studies | 29% ± 9% | |
intestine | 5 studies | 21% ± 6% | |
liver | 5 studies | 30% ± 13% | |
uterus | 4 studies | 34% ± 13% | |
placenta | 3 studies | 24% ± 6% | |
bone marrow | 3 studies | 23% ± 5% | |
eye | 3 studies | 33% ± 11% | |
breast | 3 studies | 25% ± 4% | |
adipose | 3 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 25106.29 | 1439 / 1445 | 99% | 41.37 | 181 / 183 |
thymus | 100% | 14338.76 | 652 / 653 | 98% | 28.13 | 592 / 605 |
lung | 100% | 21821.60 | 578 / 578 | 97% | 32.30 | 1121 / 1155 |
prostate | 100% | 14121.09 | 244 / 245 | 97% | 35.63 | 489 / 502 |
intestine | 100% | 20559.63 | 964 / 966 | 97% | 33.49 | 512 / 527 |
brain | 97% | 8283.88 | 2551 / 2642 | 100% | 40.55 | 703 / 705 |
bladder | 100% | 19583.10 | 21 / 21 | 93% | 28.63 | 469 / 504 |
stomach | 94% | 11054.26 | 337 / 359 | 98% | 36.47 | 279 / 286 |
breast | 100% | 25584.94 | 458 / 459 | 91% | 26.81 | 1012 / 1118 |
adrenal gland | 97% | 6737.02 | 251 / 258 | 91% | 21.42 | 210 / 230 |
kidney | 93% | 7364.69 | 83 / 89 | 95% | 39.42 | 857 / 901 |
pancreas | 88% | 5914.05 | 287 / 328 | 99% | 39.66 | 177 / 178 |
uterus | 100% | 26198.52 | 170 / 170 | 86% | 22.81 | 394 / 459 |
skin | 87% | 7707.23 | 1569 / 1809 | 97% | 34.31 | 460 / 472 |
ovary | 100% | 11772.05 | 180 / 180 | 75% | 11.62 | 321 / 430 |
adipose | 100% | 31776.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 22649.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.79 | 29 / 29 |
spleen | 100% | 15474.00 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 29.19 | 1 / 1 |
liver | 20% | 897.05 | 45 / 226 | 78% | 20.36 | 317 / 406 |
heart | 93% | 7675.20 | 799 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 19.60 | 72 / 80 |
tonsil | 0% | 0 | 0 / 0 | 89% | 23.73 | 40 / 45 |
peripheral blood | 55% | 7584.16 | 509 / 929 | 0% | 0 | 0 / 0 |
muscle | 53% | 2856.15 | 427 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008283 | Biological process | cell population proliferation |
GO_0007052 | Biological process | mitotic spindle organization |
GO_0051301 | Biological process | cell division |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0021987 | Biological process | cerebral cortex development |
GO_0030496 | Cellular component | midbody |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0046965 | Molecular function | nuclear retinoid X receptor binding |
GO_0042974 | Molecular function | nuclear retinoic acid receptor binding |
GO_0042975 | Molecular function | peroxisome proliferator activated receptor binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TACC1 |
Protein name | Transforming, acidic coiled-coil containing protein 1 variant TACC1-B Transforming acidic coiled-coil containing protein 1 Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1) Transforming acidic coiled-coil containing protein 1 (cDNA FLJ52297, highly similar to Transforming acidic coiled-coil-containing protein 1) |
Synonyms | KIAA1103 |
Description | FUNCTION: Involved in transcription regulation induced by nuclear receptors, including in T3 thyroid hormone and all-trans retinoic acid pathways . Might promote the nuclear localization of the receptors . Likely involved in the processes that promote cell division prior to the formation of differentiated tissues. . |
Accessions | A0A0C4DGD5 ENST00000518415.5 [O75410-7] E7ET87 ENST00000521528.6 ENST00000521866.5 ENST00000518809.5 ENST00000520340.5 H0YAY0 ENST00000522904.6 ENST00000524193.1 ENST00000520615.5 [O75410-3] ENST00000521935.5 E5RIP3 ENST00000317827.9 [O75410-1] E5RJG6 E5RJU4 Q8IUJ5 ENST00000519416.5 ENST00000524354.5 A0A0C4DGD3 ENST00000521642.5 E5RFM9 R4GMT7 H0YBT8 ENST00000520611.1 E7EVI4 B4E3H6 ENST00000520973.5 O75410 ENST00000276520.12 [O75410-6] ENST00000521050.5 E5RI10 |